MedPath

Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas

Phase 1
Conditions
Pancreatic Cancer
Registration Number
NCT01182831
Lead Sponsor
Asian Institute of Gastroenterology, India
Brief Summary

Coeliac plexus neurolysis (CPN) is a management option for pain control in carcinoma pancreas.CPN is conventionally performed by percutaneous technique with fluoroscopic guidance. Endoscopic ultrasound (EUS) is increasingly used for CPN as it offers a better visualization of the plexus. There are limited data comparing the two modalities.The patients are on follow-up for 6 months post neurolysis.

Detailed Description

Carcinoma pancreas patients with abdominal pain requiring daily analgesics for more than 4 weeks were included.we are randomising about 100 patients into two groups to undergo either of the two procedures, i.e. celiac plexus neurolysis by percutaneous technique or by endoscopic ultrasound guided technique.The pain scores have been recorded by visual analogue scale for an average follow-up of 6 months.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • all patients with carcinoma pancreas
Exclusion Criteria
  • patients below 18 years of age and who have not given consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
immediate pain reliefday of block to six months of follow-up
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Asian Institute of Gastroenterology

🇮🇳

Hyderabad, Andhra pradesh, India

Asian Institute of Gastroenterology
🇮🇳Hyderabad, Andhra pradesh, India
Santosh darisetty, MD
Contact
+914023378888
sant_dari@yahoo.com
srikar darisetty, MD
Contact
+914023378888
srikar.darisetty@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.